Sponsor Pipeline

Accro Bioscience (Suzhou) Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-10 NCT07755241 A Study of AC-101 Tablets in Patients With Ulcerative Colitis Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07755241 A Study of AC-101 Tablets in Patients With Ulcerative Colitis Ulcerative Colitis (UC) Not Yet Recruiting
Phase 1/2
NCT07083193 A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative… Ulcerative Colitis Recruiting
Phase 1
NCT07070674 A Phase Ib Clinical Study of AC-003 Capsules in Subjects With aGVHD. Acute Graft-versus-Host Disease Recruiting
Disease Areas
Ulcerative Colitis (2)
Get alerts when Accro Bioscience (Suzhou) Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free